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Isolated Hepatic Sarcoidosis Presenting
As Non-cirrhotic Portal Hypertension
Henry Lam, DO, Michal Kloska, MD, Reema Vaze, MD, Arjan Ahluwalia, MD, She-Yan Wong, MD
Lehigh Valley Health Network; Allentown, Pa.

Introduction

Sarcoidosis is a systemic inflammatory disease
characterized by the formation of noncaseating
granulomas. Most commonly it manifests as
diseases of the pulmonary system, although it can
involve any organ in the body. Hepatic involvement
is well known and can present as abdominal pain,
pruritus, hepatomegaly, and jaundice. Rarely does
it progress to portal hypertension or cirrhosis.
Hepatic sarcoidosis in the absence of pulmonary
involvement is seen in less than 10% of cases.
Here we highlight a case of isolated hepatic
sarcoidosis discovered incidentally presenting
as portal hypertension.

Case

A 47-year-old Caucasian male with past medical
history of type 2 diabetes mellitus, essential
hypertension, and alcohol abuse presented to the
Emergency Department after a motor vehicle
accident. Trauma workup including CT scan of the
chest, abdomen, and pelvis incidentally showed
scattered small pulmonary nodules, fatty liver, and
splenomegaly with splenic varices. Subsequent
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outpatient MRI showed hepatosplenomegaly and
portal hypertension. The patient was referred to
gastroenterology for further evaluation. Abdominal
ultrasound with doppler showed patent hepatic
vessels and normal bile ducts. Initially, it was
thought that the patient’s liver findings were
secondary to fatty liver disease given risk factors
of metabolic syndrome and daily alcohol use of
6-8 beers per day. Labs were significant for
thrombocytopenia with a platelet count of 129
thou/cmm, normal albumin of 3.6 g/dL, normal
liver function panel including total bilirubin 1.0 mg/
dL, AST 22 U/L, ALT 29 U/L, and AP 108 U/L,
and normal INR of 1.1. Serologic testing for
chronic liver disease was negative except for an
elevated smooth muscle antibody 1:160 and
serum immunoglobulin G 1827 g/L which were
suggestive of autoimmune hepatitis. An EGD
showed small esophageal varices and isolated
gastric varices in the fundus. He ultimately
underwent a percutaneous liver biopsy that
showed noncaseating granulomas without
significant fibrosis. There was no steatosis or
features of autoimmune hepatitis. Stains for

acid-fast bacilli and fungi were also negative.
The patient was diagnosed with hepatic
sarcoidosis presenting as non-cirrhotic portal
hypertension. Other organ involvement was not
found. He was started on nadolol for prophylaxis
of gastroesophageal bleeding. Treatment for
sarcoidosis was not initiated given the lack of
clinical symptoms and normal liver enzymes.

Discussion

Our case demonstrates the importance of
considering hepatic sarcoidosis as a cause of
portal hypertension. Liver involvement is common
in sarcoidosis, up to 70% of cases, but significant
complications including cirrhosis and portal
hypertension are rare, about 3%. Non-cirrhotic
portal hypertension as seen in our case is presinusoidal and thought to be secondary to
granuloma compression of the portal vein. Treatment
is reserved for those with clinical symptoms with
first line therapy being glucocorticoids. Alternatives
include ursodeoxycholic acid, immunosuppressants,
such as methotrexate and chlorambucil, and
rarely liver transplant.

Image 1. Histological slide showing liver specimen overview (100x).

Image 2. Histological slide showing liver granuloma (200x).

